[A14-14] Dimethyl fumarate - Benefit assessment according to §35a Social Code Book V (dossier assessment)
Last updated 01.08.2014
Project no.:
A14-14
Commission:
Commission awarded on 30.04.2014 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission completed
Department/Division:
Drug Assessment
Application field:
Head and nerves
Note:
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
| Project no. | Title | Status |
|---|---|---|
| A17-49 | Dimethyl fumarate (psoriasis) - Benefit assessment according to §35a Social Code Book V | Commission completed |
| A14-33 | Addendum to Commission A14-14 (dimethyl fumarate) | Commission completed |
Federal Joint Committee (G-BA)
2014-10-16 A G-BA decision was published.